(Q44588824)

4 December 2017

title

Loss of expression of tropomyosin-1, a novel class II tumor suppressor that induces anoikis, in primary breast tumors (English)

1 reference

4 December 2017

Gira N Raval

1 reference

4 December 2017

Shantaram Bharadwaj

1 reference

4 December 2017

Edward A Levine

1 reference

4 December 2017

Mark C Willingham

1 reference

4 December 2017

Randolph L Geary

1 reference

4 December 2017

Tim Kute

1 reference

4 December 2017

G L Prasad

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 December 2017

1 reference

4 December 2017

1 reference

4 December 2017

1 reference

4 December 2017

page(s)

6194-6203

1 reference

Multistep carcinogenesis of breast cancer and tumour heterogeneity

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

Tropomyosin is decreased in transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

Suppression of the transformed phenotype of breast cancer by tropomyosin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

Physiological consequences of tropomyosin mutations associated with cardiac and skeletal myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

Identification and biochemical characterization of p70TRK, product of the human TRK oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

Cytoskeletal changes in cell transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

Functional properties of non-muscle tropomyosin isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

Expression of transduced tropomyosin 1 cDNA suppresses neoplastic growth of cells transformed by the ras oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

A cDNA encoding a muscle-type tropomyosin cloned from a human epithelial cell line: identity with human fibroblast tropomyosin TM1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

Get a ligand, get a life: integrins, signaling and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

Proteomic analysis of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Increased Bcl-xL expression mediates v-Src-induced resistance to anoikis in intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Mutations in the beta-tropomyosin (TPM2) gene--a rare cause of nemaline myopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Analysis of polypeptide expression in benign and malignant human breast lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Expression of tropomyosin isoforms in benign and malignant human breast lesions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Tropomyosin-2 cDNA lacking the 3' untranslated region riboregulator induces growth inhibition of v-Ki-ras-transformed fibroblasts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Tropomyosin isoforms in nonmuscle cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Isolation and sequencing of a novel tropomyosin isoform preferentially associated with colon cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Unusual childhood extramedullary hematologic malignancy with natural killer cell properties that contains tropomyosin 4--anaplastic lymphoma kinase gene fusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Epigenetic regulation of gelsolin expression in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Platelet-derived growth factor ligand and receptor expression in response to altered blood flow in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Suppression of src-induced transformed phenotype by expression of tropomyosin-1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Opposing roles of the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase cascades in Ras-mediated downregulation of tropomyosin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Differentiation state and invasiveness of human breast cancer cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Hypermethylation of 14-3-3 sigma (stratifin) is an early event in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Src activation regulates anoikis in human colon tumor cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

The focal adhesion kinase suppresses transformation-associated, anchorage-independent apoptosis in human breast cancer cells. Involvement of death receptor-related signaling pathways.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206719

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206719

1 reference

Dimensions Publication ID

4 December 2017

1012259592

0 references

1 reference